Course Information
Description
Advances in our knowledge of the immune system are changing the ways in which we treat various types of cancer. Understanding how immune cells recognize and kill cancer cells, and what we can do to enhance their ability to fight cancer, is important for anyone working to develop new cancer treatments or apply them in the clinic. In this course, you will learn the mechanisms that underlie a number of cutting-edge cancer immunotherapies, and how they can be applied.
This is a fully online course. Students registering for this course will be automatically enrolled by HMX and will receive a confirmation email from onlinelearning@hms.harvard.edu three days prior to the HMX course start date. All course-related activities will happen through the HMX online platform. Students who complete the course will receive a Certificate of Completion. For more information please see the FAQ on the HMX website
https://learn.hms.harvard.edu/frequently-asked-questions and then click on the HMX ONLINE LEARNING link; register via my.harvard, do not use the “apply now” buttons on the HMX website.
Class Notes
Students must enroll in this course no later than September 8, 2026.
This course is intended for master's students only. Students must complete this course between September 8 and November 20, 2026.
Not Available for Cross Registration
